Juvenile Idiopathic Arthritis (JIA) Consumer Care guide
The Juvenile Idiopathic Arthritis (JIA) Consumer Care Guide has been funded by the Australian Government.
Co-designed with parents of children with JIA, the Guide is intended to empower families and carers to manage your child’s condition, and navigate the health system. It includes tips from real parents for every age and stage.
The Guide also introduces the Australian JIA Clinical Care Standards, what they mean for your child’s care, and how you can advocate to improve care. An updated version of the Clinical Care Standard is due to be released soon, and stay tuned for an update to the Guide to reflect this.
Discover more...
-
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations...
-
Arthritis Australia welcomes cheaper arthritis medicines
More medicines now eligible for 60 day dispensing from March 1 2024 [Sydney, Australia] Arthritis Australia has welcomed access to cheaper medicines commonly used to...
-
Millennials Face A Painful & Stiff Future || New Report Reveals Generations Hit Hardest with Arthritis
New forecast projections released today by Arthritis Australia reveal Millennials are facing a painful and debilitating health crisis by 2040, set to become a demographic...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
